Venoglobulin



Indications and Reactions:

Role Indications Reactions
Primary
Congenital Hypogammaglobulinaemia 100.0%
Hepatitis Infectious 100.0%
Secondary
Drug Use For Unknown Indication 75.5%
Immunosuppressant Drug Therapy 6.6%
Product Used For Unknown Indication 4.1%
Pneumonia 3.0%
Lymphoma 1.6%
Off Label Use 1.6%
Polymyositis 1.6%
Immunodeficiency Common Variable 0.8%
Primary Immunodeficiency Syndrome 0.8%
Interstitial Lung Disease 0.6%
Pneumonia Bacterial 0.6%
Rheumatoid Arthritis 0.6%
Bacterial Infection 0.4%
Selective Iga Immunodeficiency 0.4%
Blood Pressure Increased 0.3%
Disseminated Intravascular Coagulation 0.3%
Extracorporeal Circulation 0.3%
Lung Transplant 0.3%
Myasthenia Gravis 0.3%
Polyuria 0.3%
Pain 29.9%
White Blood Cell Count Decreased 20.9%
Pneumonia Staphylococcal 10.4%
Hepatitis C Rna Positive 7.5%
Sepsis 6.0%
Pneumocystis Jiroveci Pneumonia 4.5%
Drug Intolerance 3.0%
Pulmonary Oedema 3.0%
Anaphylactic Reaction 1.5%
Hepatitis C 1.5%
Renal Failure 1.5%
Septic Shock 1.5%
Shock 1.5%
Thrombocytopenia 1.5%
Transplant Rejection 1.5%
Venous Thrombosis 1.5%
Weight Decreased 1.5%
Wrong Technique In Drug Usage Process 1.5%
Concomitant
Drug Use For Unknown Indication 23.5%
Prophylaxis 9.2%
Product Used For Unknown Indication 8.2%
Pneumonia 6.8%
Multiple Myeloma 4.9%
Infection Prophylaxis 4.8%
Sepsis 4.8%
Stem Cell Transplant 4.1%
Immunosuppression 3.9%
Liver Disorder 3.5%
Idiopathic Thrombocytopenic Purpura 3.3%
Gastrointestinal Haemorrhage 3.0%
Infection 3.0%
Renal Failure Chronic 2.9%
Toxic Skin Eruption 2.9%
Pain 2.7%
Renal Transplant 2.5%
Peritonitis 2.2%
Anaemia 2.0%
Prophylaxis Against Transplant Rejection 2.0%
Pulmonary Alveolar Haemorrhage 9.1%
White Blood Cell Count Decreased 8.3%
Pneumonia 7.6%
Sepsis 7.6%
Pancytopenia 6.8%
Platelet Count Decreased 6.8%
Liver Disorder 5.3%
Renal Impairment 5.3%
Infection 4.5%
Stomatitis 4.5%
Post Procedural Haemorrhage 3.8%
Renal Failure Acute 3.8%
Somnolence 3.8%
Venous Thrombosis Limb 3.8%
White Blood Cell Count Increased 3.8%
Renal Failure 3.0%
Respiratory Disorder 3.0%
Shock 3.0%
Thrombocytopenia 3.0%
Toxic Epidermal Necrolysis 3.0%